Delivery Order SPE2DB24D1021-SPE2DB25FFARQ
- Not listed
- The Defense Logistics Agency (DLA) awarded a $33,405.75 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.5 mg softgel capsules (30-count units) on September 16, 2025, with an ultimate completion date of October 7, 2025. This non-set-aside, competitively awarded contract reflects AmerisourceBergen's role as a critical pharmaceutical distributor supporting federal medical procurement needs. The contract represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units) with a ceiling value of $11,135.25. This competitively awarded, firm fixed price delivery order is scheduled for completion by August 27, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child delivery order under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a $11,135.25 firm fixed-price delivery order to AmerisourceBergen Drug Corp for the supply of Talzenna 0.25 mg softgel capsules (30-count units) on September 9, 2025, with a completion date of September 30, 2025. This competitively awarded, non-set-aside order will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp for Talzenna 0.5 mg softgels (30-count units) on August 11, 2025, with an ultimate completion date of September 2, 2025. This is a firm fixed price, non-set-aside contract with performance executed from the company's Conshohocken, Pennsylvania location. The delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical...
- The U.S. Department of Defense's Medical Supply Chain awarded a $11,135.25 delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for the supply of Talzenna 0.35 mg softgel capsules (30-count units). This competitively awarded, non-set-aside contract utilizes firm fixed pricing and is scheduled for completion by October 6, 2025. The award represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract (SPE2DX) with Defense Logistics Agency Troop Support...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider based in Conshohocken, Pennsylvania. The contract is for the delivery of Talzenna 0.5 mg softgel capsules in 30-count packages. The award has a ceiling value of $11,135.25 and is a firm fixed-price contract. The period of performance runs through June 10, 2025. Amerisourcebergen Drug Corp holds a larger...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order valued at $10,784.34 with a completion date of February 4, 2025. It is for the supply of Talzenna 0.5 mg Capsule 30s, a pharmaceutical product. This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,424.08 firm fixed-price delivery order is for the supply of Talzenna 0.5 mg capsules. The contract has an ultimate completion date of November 27, 2024. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing...
- The Defense Logistics Agency awarded a delivery order valued at $11,135.25 to AmerisourceBergen Drug Corp for TALZENNA 0.5 mg softgels (30-count units) with a firm fixed price arrangement. The award, issued on September 4, 2025, is scheduled for completion by September 25, 2025, and represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this delivery order at its corporate...
- This federal contract award, with ID SPE2DB20D1051|SPE2DB24FD7YN, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division. The $20,848.16 Firm Fixed Price Delivery Order is for the supply of the pharmaceutical product Talzenna 0.5 mg capsules. This order is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 2025. Under this single-award...
- SPE2DB24D1021Indefinite Delivery Contract
- SPE2DB24D1021-SPE2DB25FFARQDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,270.52 to AmerisourceBergen Drug Corp for the supply of Talzenna 0.35 mg softgel capsules (30-count units) under a firm fixed-price contract. The contract, awarded on September 15, 2025, with completion targeted for October 6, 2025, represents a non-competitive delivery order placement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This award is issued as a child delivery order under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor serving as a critical federal medical supply vendor, particularly for military and veteran healthcare systems. The parent SPE2DX contract functions as a comprehensive global pharmaceutical support vehicle enabling the company to supply a diverse portfolio of medications and medical supplies to support Defense Health Agency, U.S. Coast Guard, and other government healthcare customers worldwide. The company's federal contracting history demonstrates consistent success in competitively awarded delivery orders across multiple therapeutic domains, with pricing flexibility ranging from nominal amounts to substantial orders exceeding $45,000, establishing the contractor's capability to fulfill varied federal medical procurement requirements efficiently.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $22.3k | 9/15/25 |